Wei Zeng Selected Research

Eukaryotic Initiation Factor-5 (Eukaryotic Initiation Factor 5)

8/2021

Roles of HDAC2, eIF5, and eIF6 in Lung Cancer Tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Zeng Research Topics

Disease

29	Neoplasms (Cancer) 11/2022 - 03/2006
17	Infections 01/2022 - 05/2003
11	Inflammation (Inflammations) 11/2022 - 07/2008
9	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2005
7	Diabetic Nephropathies (Diabetic Nephropathy) 05/2021 - 07/2010
5	Squamous Cell Carcinoma of Head and Neck 01/2022 - 12/2016
4	Wounds and Injuries (Trauma) 02/2022 - 01/2014
4	Neoplasm Metastasis (Metastasis) 08/2020 - 12/2014
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 09/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2020
3	Carcinogenesis 08/2021 - 03/2006
3	Stomach Neoplasms (Stomach Cancer) 05/2021 - 12/2014
3	Body Weight (Weight, Body) 04/2020 - 05/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 04/2015
3	Stroke (Strokes) 12/2018 - 01/2005
3	Thrombosis (Thrombus) 04/2018 - 02/2015
3	Hepatocellular Carcinoma (Hepatoma) 07/2016 - 01/2013
3	Atherosclerosis 03/2011 - 12/2009
3	Hypoglycemia (Reactive Hypoglycemia) 08/2006 - 12/2005
2	Alcoholism (Alcohol Abuse) 02/2022 - 03/2021
2	Chronic Subdural Hematoma 02/2022 - 03/2021
2	Heart Diseases (Heart Disease) 02/2022 - 03/2021
2	Hematoma 02/2022 - 03/2021
2	Sepsis (Septicemia) 01/2022 - 05/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 11/2021 - 01/2021
2	Neuroinflammatory Diseases 10/2021 - 02/2021
2	Lung Neoplasms (Lung Cancer) 08/2021 - 01/2018
2	Cicatrix (Scar) 07/2021 - 01/2021
2	Cognitive Dysfunction 02/2021 - 01/2021
2	Thromboembolism 01/2021 - 06/2020
2	Atrial Fibrillation 01/2021 - 12/2018
2	Thrombophilia 01/2021 - 04/2018
2	Venous Thromboembolism 01/2021 - 10/2017
2	Pneumonia (Pneumonitis) 01/2021 - 05/2020
2	Coronary Stenosis (Coronary Artery Stenosis) 11/2020 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 08/2020 - 04/2018
2	Laryngeal Neoplasms (Laryngeal Cancer) 07/2020 - 02/2016
2	Edema (Dropsy) 01/2020 - 07/2008
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 08/2019
2	Pancreatitis 01/2019 - 11/2018
2	Hypertension (High Blood Pressure) 08/2018 - 04/2010
2	Hyperglycemia 08/2018 - 04/2010
2	Adenocarcinoma 01/2018 - 10/2006
2	Esophageal Squamous Cell Carcinoma 01/2018 - 02/2016

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
8	Sitagliptin Phosphate (Januvia)FDA Link 03/2011 - 12/2005
7	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 11/2006
7	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2015
5	AnticoagulantsIBA 02/2022 - 10/2017
5	Biological ProductsIBA 01/2022 - 05/2003
5	CytokinesIBA 10/2021 - 05/2011
5	Triglycerides (Triacylglycerol)IBA 04/2020 - 03/2011
4	LipidsIBA 11/2022 - 12/2009
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2021 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2018
4	Pharmaceutical PreparationsIBA 10/2020 - 03/2007
4	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2006 - 12/2005
3	AntigensIBA 01/2022 - 01/2007
3	ElementsIBA 11/2020 - 08/2016
3	Taurine FDA Link 04/2020 - 09/2009
3	Phosphotransferases (Kinase)IBA 01/2018 - 05/2003
3	AntithrombinsIBA 01/2018 - 02/2015
3	4-phenylbutyric acid (Buphenyl)FDA Link 05/2014 - 07/2010
3	EnzymesIBA 08/2013 - 03/2006
3	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2011 - 02/2010
2	Atorvastatin (Lipitor)FDA Link 02/2022 - 03/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2022
2	ChemokinesIBA 01/2022 - 11/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	Circular RNAIBA 12/2021 - 08/2020
2	QuercetinIBA 11/2021 - 10/2020
2	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2015
2	RoflumilastIBA 08/2021 - 02/2021
2	Isoflurane FDA LinkGeneric 08/2021 - 02/2021
2	VaccinesIBA 01/2021 - 01/2007
2	C-Reactive ProteinIBA 11/2020 - 03/2011
2	Antiviral Agents (Antivirals)IBA 10/2020 - 09/2006
2	Formaldehyde (Formol)FDA Link 10/2020 - 01/2020
2	ParaffinIBA 10/2020 - 01/2020
2	Cadherins (E-Cadherin)IBA 10/2020 - 03/2006
2	Therapeutic UsesIBA 05/2020 - 04/2020
2	CholesterolIBA 04/2020 - 03/2011
2	HDL CholesterolIBA 04/2020 - 03/2011
2	LDL CholesterolIBA 04/2020 - 03/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2019 - 08/2018
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2019 - 11/2018
2	Proteasome InhibitorsIBA 01/2019 - 02/2010
2	Indicators and Reagents (Reagents)IBA 04/2018 - 08/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2015
2	emibetuzumabIBA 01/2018 - 12/2014
2	Peptide Hydrolases (Proteases)FDA Link 07/2016 - 10/2006

Therapy/Procedure

6	Therapeutics 01/2020 - 07/2008
3	Immunotherapy 01/2022 - 01/2007
2	Renal Dialysis (Hemodialysis) 02/2022 - 03/2021
2	Punctures 02/2022 - 03/2021
2	Length of Stay 01/2022 - 09/2011
2	Debridement 09/2017 - 04/2016